Cargando…

International perspectives on suboptimal patient‐reported outcome trial design and reporting in cancer clinical trials: A qualitative study

PURPOSE: Evidence suggests that the patient‐reported outcome (PRO) content of cancer trial protocols is frequently inadequate and non‐reporting of PRO findings is widespread. This qualitative study examined the factors influencing suboptimal PRO protocol content, implementation, and reporting, and u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Retzer, Ameeta, Calvert, Melanie, Ahmed, Khaled, Keeley, Thomas, Armes, Jo, Brown, Julia M., Calman, Lynn, Gavin, Anna, Glaser, Adam W., Greenfield, Diana M., Lanceley, Anne, Taylor, Rachel M., Velikova, Galina, Brundage, Michael, Efficace, Fabio, Mercieca‐Bebber, Rebecca, King, Madeleine T., Kyte, Derek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366078/ https://www.ncbi.nlm.nih.gov/pubmed/34219395 http://dx.doi.org/10.1002/cam4.4111

Ejemplares similares

Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials
por: Kyte, Derek, et al.
Publicado: (2019)

Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol
por: Retzer, Ameeta, et al.
Publicado: (2018)

Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol
por: Ahmed, Khaled, et al.
Publicado: (2016)

Systematic review of the use of translated patient-reported outcome measures in cancer trials
por: Slade, A. L., et al.
Publicado: (2021)

The administration of patient-reported outcome questionnaires in cancer trials: Interviews with trial coordinators regarding their roles, experiences, challenges and training
por: Mercieca-Bebber, Rebecca, et al.
Publicado: (2017)

Patient-Reported Outcome (PRO) Assessment in Clinical Trials: A Systematic Review of Guidance for Trial Protocol Writers
por: Calvert, Melanie, et al.
Publicado: (2014)

Systematic Evaluation of the Patient-Reported Outcome (PRO) Content of Clinical Trial Protocols
por: Kyte, Derek, et al.
Publicado: (2014)

A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: implications for generalisability and clinical practice
por: Mercieca-Bebber, Rebecca, et al.
Publicado: (2017)

Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review
por: Mercieca-Bebber, Rebecca, et al.
Publicado: (2016)

Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews
por: Mercieca-Bebber, Rebecca, et al.
Publicado: (2022)

The importance of patient-reported outcomes in clinical trials and strategies for future optimization
por: Mercieca-Bebber, Rebecca, et al.
Publicado: (2018)

‘Give Us The Tools!’: development of knowledge transfer tools to support the involvement of patient partners in the development of clinical trial protocols with patient-reported outcomes (PROs), in accordance with SPIRIT-PRO Extension
por: Cruz Rivera, Samantha, et al.
Publicado: (2021)

The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice
por: Calvert, Melanie, et al.
Publicado: (2013)

SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials
por: Calvert, Melanie, et al.
Publicado: (2021)

Electronic patient reported outcomes to support care of patients with traumatic brain injury: PRiORiTy study qualitative protocol
por: Retzer, Ameeta, et al.
Publicado: (2019)

A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancer
por: Wilson, Michelle K., et al.
Publicado: (2018)

Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards
por: Brundage, Michael, et al.
Publicado: (2012)

Development of a core outcome set for use in community-based bipolar trials—A qualitative study and modified Delphi
por: Retzer, Ameeta, et al.
Publicado: (2020)

The PROTEUS-Trials Consortium: Optimizing the use of patient-reported outcomes in clinical trials
por: Snyder, Claire, et al.
Publicado: (2022)

Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops
por: King, Madeleine T., et al.
Publicado: (2022)

Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists
por: Kyte, Derek, et al.
Publicado: (2013)

Inconsistencies in Quality of Life Data Collection in Clinical Trials: A Potential Source of Bias? Interviews with Research Nurses and Trialists
por: Kyte, Derek, et al.
Publicado: (2013)

Current practices in patient-reported outcome (PRO) data collection in clinical trials: a cross-sectional survey of UK trial staff and management
por: Kyte, Derek, et al.
Publicado: (2016)

Patient Reported Outcomes (PROs) in Clinical Trials: Is ‘In-Trial’ Guidance Lacking? A Systematic Review
por: Kyte, Derek G., et al.
Publicado: (2013)

Management of Patient-Reported Outcome (PRO) Alerts in Clinical Trials: A Cross Sectional Survey.
por: Kyte, Derek, et al.
Publicado: (2016)

Correction: Patient Reported Outcomes (PROs) in Clinical Trials: Is ‘In-Trial’ Guidance Lacking? A Systematic Review
por: Kyte, Derek G., et al.
Publicado: (2014)

Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance
por: Aiyegbusi, Olalekan Lee, et al.
Publicado: (2022)

Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra study
por: Retzer, Ameeta, et al.
Publicado: (2022)

Maternal filicide in a cohort of English Serious Case Reviews
por: Sidebotham, Peter, et al.
Publicado: (2018)

The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders
por: Cruz Rivera, Samantha, et al.
Publicado: (2020)

Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: a systematic review protocol
por: Aiyegbusi, Olalekan Lee, et al.
Publicado: (2016)

Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial
por: McMullan, Christel, et al.
Publicado: (2023)

Patient-Reported Outcomes Associated with Treatments for Testicular Cancer: A Systematic Review
por: Mercieca-Bebber, Rebecca, et al.
Publicado: (2021)

Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review
por: Aiyegbusi, Olalekan Lee, et al.
Publicado: (2017)

Patient-reported outcome measures used in patients with primary sclerosing cholangitis: a systematic review
por: Isa, Fatima, et al.
Publicado: (2018)

A Factorial Survey Investigating the Effect of Disclosing Parental Intellectual Disability on Risk Assessments by Children’s Social Workers in Child Safeguarding Scenarios
por: Retzer, Ameeta, et al.
Publicado: (2020)

Rescuing Suboptimal Patient-Reported Outcome Instrument Data in Clinical Trials: A New Strategy
por: Yang, Chengwu, et al.
Publicado: (2018)

The reporting quality of abstracts of stepped wedge randomized trials is suboptimal: A systematic survey of the literature
por: Wang, Mei, et al.
Publicado: (2017)

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
por: Mercieca-Bebber, R., et al.
Publicado: (2022)

Feasibility of a new electronic patient-reported outcome (ePRO) system for an advanced therapy clinical trial in immune-mediated inflammatory disease (PROmics): protocol for a qualitative feasibility study
por: Hughes, Sarah E, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1fq6v8hqmho948pv53geckpt7g